Aashka Hospitals has scheduled its 14th Annual General Meeting for September 24, 2026. The agenda includes the reappointment of Bipinchandra D. Shah as Chairman and Managing Director and proposals to increase borrowing limits to ₹25 crore.

The Board of Directors held its meeting on August 27, 2026, approving the notice for the AGM and confirming that it will not incorporate its proposed subsidiary, Aashka – Rhythm Hospitals Private Limited. This strategic reversal follows an earlier intimation in July regarding the acquisition by way of incorporation.

AGM Details

The meeting will be held at 11:30 am at Between Sargasan and Reliance Cross Road, Sargasan, Gandhinagar. Remote e-voting will be open from September 21 to September 23, 2026. The cut-off date for voting rights is September 17, 2026.

Key Resolutions

Shareholders will vote on several ordinary and special business items:

• Adoption of Financial Statements: Approval of audited financials for FY26, which reported total income of ₹2,527.94 lakh and net profit of ₹333.89 lakh.
• Reappointment of CMD: Bipinchandra D. Shah’s reappointment for three years, effective September 20, 2026, with a basic salary of ₹10 lakh per month plus perquisites up to ₹10 lakh per month.
• Borrowing Limit Increase: Approval to borrow up to ₹25 crore under Section 180(1)(c) of the Companies Act, 2013.
• Investment Authority: Authorization to make investments, loans, or guarantees up to ₹50 crore under Section 186 of the Companies Act, 2013.

Financial Context

For FY26, the company reported a net profit of ₹333.89 lakh, compared to ₹326.61 lakh in FY25. Total income declined slightly to ₹2,527.94 lakh from ₹2,598.54 lakh in the previous year. The company has not declared any equity dividend in the last three fiscal years.

Aashka Hospitals Limited has entered into a Memorandum of Understanding (MoU) on August 7, 2026, to acquire a 70% controlling stake in a newly formed entity comprising four Rhythm Group healthcare businesses. The strategic partnership aims to consolidate Rhythm Medical Stores, Rhythm Multispeciality Hospital, Cardioplus Heart Care, and Rhythm Medical & Heart Hospital into a single corporate structure, giving Aashka majority voting rights and board control.

The move represents a significant expansion for Aashka Hospitals, allowing it to integrate multiple specialty facilities under one umbrella. The company will acquire the 70% equity shares from existing shareholders of the newly emerged entity at a price determined through valuation on the transaction date. No shares are being issued to Aashka Hospitals Limited at this stage; the acquisition involves purchasing existing equity.

The transaction has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also references Securities and Exchange Board of India Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Aashka Hospitals confirmed that there is no primary relationship between the parties prior to this agreement, meaning the transaction does not fall within the definition of related-party transactions.

Key Terms of the Strategic Partnership

Upon completion of the restructuring, the newly emerged company will become a related party to Aashka Hospitals Limited. The MoU grants Aashka the right to appoint directors and restrict changes in the capital structure of the new entity. The agreement does not involve any loan agreements or nominee disclosures that would create potential conflicts of interest.

What This Means for Expansion

By consolidating four distinct healthcare entities into one subsidiary with majority ownership, Aashka Hospitals can streamline operations and leverage synergies across multispecialty services, cardiac care, and medical supplies. The 70% holding ensures decisive control over strategic decisions while potentially allowing minority interests from the original Rhythm Group stakeholders to remain invested. This approach minimizes integration risks compared to a full buyout, as existing management may retain operational roles under the new structure.

The absence of a disclosed monetary value for the agreement suggests the final consideration depends on independent valuations yet to be finalized. Investors should monitor subsequent filings for details on the valuation methodology, timeline for closing, and any regulatory approvals required for the restructuring.